Table 2 General characteristics of men (n = 931) and women (n = 1217) according to eGFR category. The quantitative values are expressed by median and interquartile difference, qualitative values as number and percentage
From: Association between kidney function, nutritional status and anthropometric measures in older people
Variable | Men | Women | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
G1–2 (≥60) N = 315 | G3A (45–59.9) N = 368 | G3B (30–44.9) N = 198 | G4 (15–30) N = 50 | p-value* | G1–2 (≥60) N = 503 | G3A (45–59.9) N = 483 | G3B (30–44.9) N = 193 | G4 (15–30) N = 38 | p-value* | |
Age (years) | 78.7 (4.6) | 79.6 (6.0) | 80.1 (6.0) | 83.2 (7.3) | < 0.001abcdef | 78.6 (4.4) | 79.7 (5.7) | 83.1 (7.9) | 81.9 (6.8) | < 0.001 abcdef |
Education (years) | 12 (8) | 12 (7) | 11 (6) | 9 (5) | 0.031 bcdef | 12 (7) | 11 (6) | 10 (5) | 8 (3) | < 0.001 abcdef |
Weight (kg) | 77.0 (14.3) | 78.0 (17.0) | 81.4 (16.2) | 75.5 (18.0) | < 0.001 abcdef | 65.0 (16.0) | 67.0 (18.0) | 69.4 (19.6) | 72.7 (16.6) | < 0.001 abcdef |
Arm circumference (cm) | 28 (3.8) | 28 (3.0) | 29 (3.0) | 28 (5.0) | < 0.001 bdf | 28 (4.5) | 28 (4.5) | 28 (5.0) | 28 (5.0) | < 0.001 bcde |
Waist circumference (cm) | 100 (14.0) | 101 (13.9) | 104 (13.0) | 102 (14.8) | < 0.001 bdf | 92 (17.0) | 95 (16.0) | 98 (16.0) | 102 (13.2) | < 0.001 abcdef |
Hip circumference (cm) | 102 (9.0) | 103 (9.0) | 106 (9.0) | 105 (10.0) | < 0.001 bcde | 102 (12.0) | 105 (13.4) | 108 (15.0) | 111 (11.0) | < 0.001 abcdef |
Calf circumference (cm) | 36 (4) | 36 (5) | 38 (7) | 42 (8) | < 0.001 bcdef | 35 (4) | 36 (5) | 36 (6) | 41 (13) | < 0.001 abcef |
BMI (kg/m2) | 26.9 (4.5) | 27.2 (5.0) | 27.7 (4.9) | 26.7 (4.7) | 0.011 abcef | 26.6 (5.8) | 27.6 (6.0) | 28.5 (7.0) | 29.6 (7.5) | < 0.001 abcdef |
WHR | 1 (0.1) | 1 (0.1) | 1 (0.1) | 1 (0.1) | ns | 0.89 (0.1) | 0.89 (0.1) | 0.89 (0.1) | 0.90 (0.1) | ns |
WHtR | 0.59 (0.1) | 0.60 (0.1) | 0.61 (0.1) | 0.60 (0.1) | < 0.001 bcdef | 0.6 (0.1) | 0.6 (0.1) | 0.6 (0.1) | 0.7 (0.1) | < 0.001 cef |
MNA SF | 14 (2) | 14 (1) | 14 (2) | 14 (3) | ns | 13 (2) | 13 (2) | 13 (2) | 13 (3) | ns |
MNA | 27 (2.5) | 27 (2.5) | 27 (2.5) | 26 (4.7) | < 0.001 cef | 27 (3.0) | 26.5 (3.5) | 26 (3.0) | 25.0 (6.2) | < 0.001 c |
Albumin (g/dL) | 4.3 (0.4) | 4.3 (0.4) | 4.3 (0.4) | 4.0 (0.5) | < 0.001 cef | 4.3 (0.4) | 4.2 (0.5) | 4.2 (0.5) | 4.0 (0.6) | < 0.001 c |
Diabetes (n, %) | 75 (23.8) | 104 (28.3) | 83 (41.9) | 17 (34.0) | < 0.001 abcdef | 79 (15.7) | 88 (18.2) | 70 (36.3) | 16 (42.1) | < 0.001 abcdef |
Cancer (n, %) | 51 (16.2) | 76 (20.7) | 49 (24.7) | 12 (24.0) | ns | 65 (12.9) | 78 (16.1) | 29 (15.0) | 6 (15.8) | ns |
Hypertension (n, %) | 201 (63.8) | 281 (76.4) | 177 (89.4) | 47 (94.0) | < 0.001 abcdef | 341 (67.8) | 378 (78.3) | 169 (87.6) | 38 (100.0) | < 0.001 abcdef |
CAD (n, %) | 36 (21.2) | 68 (40.0) | 56 (32.9) | 10 (5.9) | < 0.001 abcdef | 36 (7.2) | 36 (7.5) | 36 (18.7) | 9 (23.7) | < 0.001 bcdef |
CVD (n, %) | 39 (12.4) | 57 (15.5) | 30 (15.2) | 6 (12.0) | ns | 48 (9.5) | 49 (10.1) | 30 (15.5) | 9 (23.7) | 0.009 bcdef |
CHF (n, %) | 26 (8.3) | 74 (20.1) | 51 (25.8) | 15 (30.0) | < 0.001 abcdef | 42 (8.3) | 75 (15.5) | 40 (20.7) | 11 (28.9) | < 0.001 abcdef |
COPD (n, %) | 40 (12.7) | 59 (16.0) | 44 (22.2) | 13 (26.0) | 0.011 abcdef | 30 (6.0) | 36 (7.5) | 25 (13.0) | 5 (13.2) | 0.012 abcdef |
Metabolic syndrome (n, %) | 161 (51.1) | 213 (57.9) | 145 (73.2) | 36 (72.0) | < 0.001 abcdef | 242 (48.1) | 289 (59.8) | 140 (72.5) | 30 (78.9) | < 0.001 abcdef |
CIRS-G | 7 (6) | 8 (6) | 10 (8) | 12 (7) | < 0.001 abcdef | 6 (5) | 7 (6) | 11 (7) | 12 (6) | < 0.001 abcde |
Country | ||||||||||
Austria (n, %) | 12 (3.8) | 34 (9.2) | 44 (22.2) | 26 (52.0) | < 0.001 abcdef | 18 (3.6) | 37 (7.7) | 34 (17.6) | 18 (47.4) | < 0.001 abcdef |
Germany (n, %) | 32 (10.2) | 35 (9.5) | 12 (6.1) | 4 (8.0) | ns | 74 (14.7) | 69 (14.3) | 39 (20.2) | 5 (13.2) | ns |
Israel (n, %) | 64 (20.3) | 54 (14.7) | 17 (8.6) | 3 (6.0) | 0.001 abcde | 85 (16.9) | 58 (12.0) | 16 (8.3) | 1 (2.6) | 0.002 abcdef |
Italy (n, %) | 73 (23.2) | 101 (27.4) | 44 (22.2) | 3 (6.0) | 0.008 acdef | 82 (16.3) | 107 (22.2) | 23 (11.9) | 3 (7.9) | 0.003 abcdef |
The Netherlands (n, %) | 43 (13.7) | 61 (16.6) | 46 (23.2) | 10 (20.0) | 0.042 abcdef | 47 (9.3) | 40 (8.3) | 32 (16.6) | 6 (15.8) | 0.008 cde |
Poland (n, %) | 49 (15.6) | 42 (11.4) | 10 (5.1) | 0 (0.0) | < 0.001 abcdef | 111 (22.1) | 115 (23.8) | 25 (13.0) | 0 (0.0) | < 0.001 bcdef |
Spain (n, %) | 42 (13.3) | 41 (11.1) | 25 (12.6) | 4 (8.0) | ns | 86 (17.1) | 57 (11.8) | 24 (12.4) | 5 (13.2) | ns |